Advanced search
Publication Cover
Psoriasis: Targets and Therapy Volume 12, 2022 - Issue
Submit an article Journal homepage
462
Views
12
CrossRef citations to date
0
Altmetric
REVIEW

Towards Personalized Medicine in Psoriasis: Current Progress

Elisa Camela1 Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7201-9163
ORCID Icon,
Luca Potestio1 Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyORCID Iconhttps://orcid.org/0000-0001-5940-0592
ORCID Icon,
Angelo Ruggiero1 Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyORCID Iconhttps://orcid.org/0000-0002-4658-7391
ORCID Icon,
Sonia Sofia Ocampo-Garza2 Dermatology Department, Universidad Autónoma de Nuevo León, University Hospital ¨Dr. José Eleuterio González¨, Monterrey, Nuevo León, México
,
Gabriella Fabbrocini1 Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
&
Matteo Megna1 Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy
Pages 231-250 | Received 30 Jun 2022, Accepted 13 Aug 2022, Published online: 01 Sep 2022

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (10)

Luca Potestio, Angelo Ruggiero, Gabriella Fabbrocini, Fabrizio Martora & Matteo Megna. (2023) Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature. Psoriasis: Targets and Therapy 13, pages 19-26.
Read now
Luca Potestio, Fabrizio Martora, Gabriella Fabbrocini, Teresa Battista & Matteo Megna. (2023) Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis. Psoriasis: Targets and Therapy 13, pages 11-18.
Read now
Luca Potestio, Ilaria Piscitelli, Gabriella Fabbrocini, Fabrizio Martora, Angelo Ruggiero & Matteo Megna. (2023) Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection. Clinical, Cosmetic and Investigational Dermatology 16, pages 369-373.
Read now
Fabrizio Martora, Matteo Megna, Teresa Battista, Luca Potestio, Maria Carmela Annunziata, Claudio Marasca, Alessia Villani & Gabriella Fabbrocini. (2023) Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience. Clinical, Cosmetic and Investigational Dermatology 16, pages 135-148.
Read now
Elisa Camela, Luca Potestio, Gabriella Fabbrocini, Sabatino Pallotta & Matteo Megna. (2023) The holistic approach to psoriasis patients with comorbidities: the role of investigational drugs. Expert Opinion on Investigational Drugs 32:6, pages 537-552.
Read now
Matteo Megna, Elisa Camela, Teresa Battista, Lucia Genco, Fabrizio Martora, Matteo Noto, Vincenzo Picone, Angelo Ruggiero, Giuseppe Monfrecola, Gabriella Fabbrocini & Luca Potestio. (2023) Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients. Expert Opinion on Drug Safety 22:1, pages 43-58.
Read now
Matteo Megna, Elisa Camela, Teresa Battista, Lucia Genco, Fabrizio Martora, Matteo Noto, Vincenzo Picone, Angelo Ruggiero, Giuseppe Monfrecola, Gabriella Fabbrocini & Luca Potestio. (2023) Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients. Expert Opinion on Drug Safety 22:1, pages 25-41.
Read now
Fabrizio Martora, Teresa Battista, Claudio Marasca, Lucia Genco, Gabriella Fabbrocini & Luca Potestio. (2022) Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature. Clinical, Cosmetic and Investigational Dermatology 15, pages 2369-2382.
Read now
Angelo Ruggiero, Fabrizio Martora, Gabriella Fabbrocini, Alessia Villani, Claudio Marasca, Matteo Megna, Luigi Fornaro, Rosita Comune & Luca Potestio. (2022) The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review. Clinical, Cosmetic and Investigational Dermatology 15, pages 2785-2793.
Read now
Angelo Ruggiero, Elisa Camela, Luca Potestio, Gabriella Fabbrocini & Matteo Megna. (2022) Drug safety evaluation of tildrakizumab for psoriasis: a review of the current knowledge. Expert Opinion on Drug Safety 21:12, pages 1445-1451.
Read now

Articles from other publishers (2)

Zhibing Fu, Yi He, Lihua Gao, Xiaoliang Tong, Lu Zhou & Jinrong Zeng. (2023) STAT2 /Caspase3 in the diagnosis and treatment of psoriasis . European Journal of Clinical Investigation 53:6.
Crossref
Lorena Aguilera-Cobos, Patricia García-Sanz, María Piedad Rosario-Lozano, M. Gonzalo Claros & Juan Antonio Blasco-Amaro. (2023) An innovative framework to determine the implementation level of personalized medicine: A systematic review. Frontiers in Public Health 11.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.